Brainsway (BRSYF) Free Cash Flow (2025 - 2026)
Brainsway posted quarterly Free Cash Flow of $1.2 million for Q1 2026, down 76.63% year-on-year from $5.0 million in Q1 2025, and down 76.63% on a QoQ basis from $5.0 million in Q1 2025.
Brainsway (BRSYF) has 2 years of Free Cash Flow data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 76.63% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $6.2 million (up 23.37% YoY), and the FY2025 full-year result was $17.5 million, up 69.82% from the prior year.
- Free Cash Flow for Q1 2026 stood at $1.2 million, down from $5.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $5.0 million in Q1 2025 and bottomed at $1.2 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Brainsway | - | - | 11.68 Mn | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Mn |
| Mar 31, 2026 | 1.17 Mn |
| Mar 31, 2025 | 5.01 Mn |
| Mar 31, 2025 | 5.01 Mn |